Petrariu Oana-Alina, Barbu Ilda Czobor, Niculescu Adelina-Gabriela, Constantin Marian, Grigore Georgiana Alexandra, Cristian Roxana-Elena, Mihaescu Grigore, Vrancianu Corneliu Ovidiu
Microbiology-Immunology Department, Faculty of Biology, University of Bucharest, Bucharest, Romania.
The Research Institute of the University of Bucharest, Bucharest, Romania.
Front Microbiol. 2024 Jan 5;14:1296447. doi: 10.3389/fmicb.2023.1296447. eCollection 2023.
The imbalance of microbial composition and diversity in favor of pathogenic microorganisms combined with a loss of beneficial gut microbiota taxa results from factors such as age, diet, antimicrobial administration for different infections, other underlying medical conditions, etc. Probiotics are known for their capacity to improve health by stimulating the indigenous gut microbiota, enhancing host immunity resistance to infection, helping digestion, and carrying out various other functions. Concurrently, the metabolites produced by these microorganisms, termed postbiotics, which include compounds like bacteriocins, lactic acid, and hydrogen peroxide, contribute to inhibiting a wide range of pathogenic bacteria. This review presents an update on using probiotics in managing and treating various human diseases, including complications that may emerge during or after a COVID-19 infection.
微生物组成和多样性失衡,有利于致病微生物,同时有益的肠道微生物群分类群丧失,这是由年龄、饮食、针对不同感染使用抗菌药物、其他潜在疾病等因素导致的。益生菌以其通过刺激肠道内微生物群、增强宿主抗感染免疫力、促进消化以及发挥各种其他功能来改善健康状况而闻名。同时,这些微生物产生的代谢产物,称为后生元,包括细菌素、乳酸和过氧化氢等化合物,有助于抑制多种病原菌。本综述介绍了益生菌在管理和治疗各种人类疾病方面的最新进展,包括新冠病毒感染期间或之后可能出现的并发症。